Recently, however, researchers have discovered an increasing correlation between some liver cancers and non-viral chronic ...

Hepatocellular carcinoma (HCC ... In recent years, there has been an increase in HCC cases related to alcohol-related liver ...

Furthermore, patients who recovered from MAFLD showed a higher incidence rate of hepatocellular carcinoma than those without the disease. This suggests that additional information can be provided ...

As India marks World Liver Day, health experts are raising concerns over the rising burden of liver cancer, a disease often ...

Long-term use of statins may delay or deflect the development of hepatocellular carcinoma in adults with chronic liver disease, as well as in the general population, emerging research, including ...

During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...

The mechanism by which patients with portal hypertension develop portal hypertensive gastropathy has yet to be fully clarified. Its pathogenesis is known to be multifactorial, involving elevations ...

EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation from the FDA.

The FDA has granted approval to nivolumab plus ipilimumab for use in unresectable or metastatic hepatocellular carcinoma.

Doer Biologics begins patient dosing in phase 2 study of DR10624 to treat metabolic dysfunction-associated steatotic liver disease and MASH: Hangzhou, China Thursday, April 24, 20 ...

Agenus Inc. (Nasdaq: AGEN), a clinical-stage immuno-oncology company, today announced updated data from the hepatocellular carcinoma (HCC) cohort of its ongoing Phase 1 study evaluating botensilimab ...